This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Nemaura Medical Yönetim
Yönetim kriter kontrolleri 2/4
Nemaura Medical's CEO is Faz Chowdhury, appointed in Jan 2009, has a tenure of 15.25 years. total yearly compensation is $338.58K, comprised of 29.2% salary and 70.8% bonuses, including company stock and options. directly owns 30.29% of the company’s shares, worth €725.32K. The average tenure of the management team and the board of directors is 3.2 years and 1.7 years respectively.
Anahtar bilgiler
Faz Chowdhury
İcra Kurulu Başkanı
US$338.6k
Toplam tazminat
| CEO maaş yüzdesi | 29.2% |
| CEO görev süresi | 15.3yrs |
| CEO sahipliği | 30.3% |
| Yönetim ortalama görev süresi | 3.2yrs |
| Yönetim Kurulu ortalama görev süresi | 1.7yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$11m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | US$339k | US$99k | -US$14m |
| Dec 31 2022 | n/a | n/a | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$15m |
| Jun 30 2022 | n/a | n/a | -US$14m |
| Mar 31 2022 | US$113k | US$109k | -US$14m |
| Dec 31 2021 | n/a | n/a | -US$12m |
| Sep 30 2021 | n/a | n/a | -US$10m |
| Jun 30 2021 | n/a | n/a | -US$9m |
| Mar 31 2021 | US$108k | US$105k | -US$6m |
| Dec 31 2020 | n/a | n/a | -US$5m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | US$104k | US$102k | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$4m |
| Sep 30 2019 | n/a | n/a | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | US$105k | US$104k | -US$4m |
| Dec 31 2018 | n/a | n/a | -US$3m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | US$107k | US$106k | -US$2m |
Tazminat ve Piyasa: Faz's total compensation ($USD338.58K) is about average for companies of similar size in the German market ($USD394.95K).
Tazminat ve Kazançlar: Faz's compensation has increased whilst the company is unprofitable.
CEO
Faz Chowdhury (50 yo)
15.3yrs
Görev süresi
US$338,578
Tazminat
Dr. Dewan Fazlul Hoque Chowdhury, also known as Faz, Ph. D, founded Nemaura Pharma Limited and also serves as its Chief Executive Officer and Chairman of the Board since 2005. Dr. Chowdhury has been the Ch...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman | 15.3yrs | US$338.58k | 30.29% € 725.3k | |
| Chief Operating Officer | 2.3yrs | Veri yok | 0.35% € 8.3k | |
| Head of U.S. Commercial Operations | 3.2yrs | Veri yok | Veri yok | |
| Head of E.U. Commercial Operations & Marketing | 3.2yrs | Veri yok | Veri yok | |
| Global Head of Digital Programs | 3yrs | Veri yok | Veri yok |
3.2yrs
Ortalama Görev Süresi
Deneyimli Yönetim: N18A's management team is considered experienced (3.2 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman | 15.3yrs | US$338.58k | 30.29% € 725.3k | |
| Advisor of International Growth Opportunities & Member of Executive Advisory Board | 3.1yrs | Veri yok | Veri yok | |
| Director | 10.3yrs | Veri yok | 9.66% € 231.2k | |
| Independent Director | less than a year | Veri yok | Veri yok | |
| Director | less than a year | Veri yok | Veri yok | |
| Director | less than a year | Veri yok | Veri yok |
1.7yrs
Ortalama Görev Süresi
50yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: N18A's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.